Abstract: Two series of diversely substituted 1-(3,5-dimethyl-4-(substitutedphenyldiazenyl)-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl)oxy)ethanones (8a-g) and 3-methyl-1-(2-((2-methylquinolin-8-yl)oxy)acetyl)-4-(2-substitutedphenylhydrazono)-1H-pyrazol-5(4H)-ones (9a-h) were synthesized. All the newly synthesized compounds were characterized by IR, 1 H NMR, 13 C NMR, Mass and chemical analysis. The compounds were evaluated for their in vitro antibacterial activity against some Gram-positive bacteria, Staphylococcus aureus, Bacillus subtilis, Gram-negative bacteria, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi and screened for antifungal activity against Aspergillus niger, Ustilago maydis using the agar disc diffusion method. All the tested compounds showed significant antibacterial activity against both the strains with compounds 8d and 9d being more potent.
Introduction
Heterocyclic compounds played a vital role in biological processes and are wide spread as natural products. They are widely found in nature particularly in nucleic acids, plant alkaloids, anthocyanins and flavones as well as in haem and chlorophyll. Additionally some vitamins, proteins, hormones contain aromatic heterocyclic system. Synthetically produced heterocycles designed by organic chemists are used for instance as agrochemicals and pharmaceuticals and play an important role in human life. Heterocycles have enormous potential as the most promising molecules as lead structures for the design of new drugs [1] [2] [3] [4] .
Pyrazoles have a unique place and contributed significantly to biological, medicine, pharmacology fields. Pyrazole ring containing substituted five membered ring exhibited antibacterial, antifungal, tumor-necrosis inhibitor, antimicrobial, hypoglycemic, hypolipidemic and anti-inflammatory activity [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . On the other hand quinoline and their RESEARCH ARTICLE derivatives could be considered as possible antimalarial, anti-bacterial, antifungal, anthelmintic, cardiovascular, anticonvulsant, anti-inflammatory and analgesic activity [16] [17] [18] [19] [20] [21] . Hence it was thought of interest to accommodate pyrazole and quinoline moieties in a singular molecular frame work to synthesize the linked heterocyclics for enhancing biological activity. Two different series of quinoline ring substituted pyrazole derivatives (8a-g and 9a-h) were synthesised and screened for their antibacterial activity.
Experimental
Melting points were determined in open capillaries on a Mel-Temp apparatus and are uncorrected. The homogeneity of the compounds was checked by TLC (silica gel H, BDH, ethyl acetate-hexane, 3:5) . The IR spectra were recorded on Perkin Elmer 100 FT-IR spectrometer as KBr pellets. The wave numbers were given in cm -1 . The 1 H NMR spectra were recorded in CDCl 3 /DMSO-d 6 on a jeol JNM λ-400 MHz machine. The 13 C NMR spectra were recorded in CDCl 3 /DMSO-d 6 on a Jeol JNM spectrometer operating at 100 MHz. All chemical shifts are reported in δ (ppm) using TMS as an internal standard. The mass spectra were recorded on VG 7070H mass spectrometer. The microanalyses were performed on Perkin-Elmer 240C elemental analyzer. All newly synthesized compounds yielded spectral data consistent with the proposed structure and microanalysis data are in agreement with the theoretical values.
Synthesis of ethyl 2-((2-methylquinolin-8-yl)oxy)acetate (2)
A mixture of 2-methylquinolin-8-ol (1) 0.01 mole, ethyl chloroacetate (0.01 mole) and anhydrous K 2 CO 3 (1.38 g, 0.01 mole and 10 mL of DMF) was subjected to agitation at room temperature for 8 h. The reaction mixture was diluted with ice cold water and the separated product was filtered, washed with water and recrystallized from ethanol. 80% yield, mp 55°-57 °C.
IR 
Synthesis of 2-((2-methylquinolin-8-yl)oxy)acetohydrazide (3)
To a solution of ethyl 2-((2-methylquinolin-8-yl)oxy)acetate (2) (0.01 mole) in methanol, hydrazine hydrate (0.02 mole) was added and the reaction mixture was refluxed for 8 h. The excess of the solvent was distilled off and the reaction mixture was cooled. 
General procedure for the synthesis of 1-chloro-2-substitutedphenyldiazene (5a-h)
The required primary amine (4a-h) was dissolved in a suitable volume of water containing 2.5-3.5 equivalents of hydrochloride acid or (sulphuric acid) by the application of heat if necessary 22 . The solution thus obtained was cooled to 0 o C where the amine hydrochloride or (sulphate) usually crystallizes. The temperature was maintained at 0° to 5 o C and the aqueous sodium nitrite solution was added portion wise till there was free nitrous acid. The solution was tested for the later with an external indicator paper (moist potassium iodidestarch paper). An excess of acid was maintained to stabilize the diazonium salt solution. However, in those cases where a large excess of acid was harmful, the concentration of the acid was reduced to optimum value.
General procedure for the synthesis of compounds (6a-g)
A solution of sodium acetate (100 g) in 100 mL aqueous alcohol (50%) was added to a solution of acetylacetone (100 g) in 500 mL of ethanol and the mixture was cooled. To this cold mixture, the corresponding diazonium chloride (5) was added gradually till turbidity was observed 6 . The addition was continued till yellow crystals separated out. These crystals were filtered washed with water and recrystallized from ethanol. Compounds 6a-g are synthesized on the same lines. Yield 70-85%; m.p: 6a, 92ᵒ C; 6b, 98ᵒ C; 6c, 139-140ᵒ C; 6d, 233ᵒ C; 6e, 112ᵒ C; 6f, 120ᵒ C; 6g, 120-122 °C.
General procedure for the synthesis of compounds (7a-h)
A solution of sodium acetate (100 g) in 100 mL aqueous alcohol (50%) was added to a solution of ethyl acetoacetate (100 g) in 500 mL of ethanol and the mixture was cooled. To this cold mixture, the corresponding diazonium chloride (5) was added gradually till turbidity was observed 6 . The addition was continued till yellow crystals separated out. These crystals were filtered washed with water and recrystallized from ethanol. Compounds 7a-h are synthesized on the same lines. Yield 70-85%; m.p: 7a, 184ᵒ C; 7b, 178-179ᵒ C; 7c, 116-118ᵒ C; 7d, 195-196ᵒ C; 7e, 119-120ᵒ C; 7f, 125-126ᵒ C; 7g, 90-91° C; 7h, 89-91 °C.
General procedure for the synthesis of compounds (8a-g)
A mixture of 3-(phenyldiazenyl) pentane-2,4-dione (6a-g) (0.01 mol) and 2-((2-methylquinolin-8-yl)oxy)acetohydrazide (3) 0.01 mol in ethanol (20 mL) was heated under reflux for 8 h. on a water bath. After completion of the reaction, ethanol was evaporated; the residue was dissolved in water, neutralized with NaHCO 3 and extracted with ether. The ether solution was evaporated under reduced pressure to furnish the pure compounds. 
1-(
3,5-Dimethyl-4-(phenyldiazenyl)-1H-pyrazol-1-yl)-2-((2-methylquinolin-8- yl)oxy)ethanone (8a)
1-(3,5-Dimethyl-4-(p-tolyldiazenyl)-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl) oxy) ethanone (8b)

1-(4-((4-Chlorophenyl)diazenyl)-3,5-dimethyl-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl)oxy)ethanone (8c)
1-(3,5-Dimethyl-4-((4-nitrophenyl)diazenyl)-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl)oxy)ethanone (8d)
Recrystallised
1-(4-((2-Methoxyphenyl)diazenyl)-3,5-dimethyl-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl)oxy)ethanone (8e)
1-(4-((2-chlorophenyl)diazenyl)-3,5-dimethyl-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl)oxy)ethanone (8f)
1-(3,5-Dimethyl-4-((2-nitrophenyl)diazenyl)-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl)oxy)ethanone (8g)
General procedure for the synthesis of compounds 9a-h
A mixture of methyl 3-oxo-2-(phenyldiazenyl)butanoate (7a-h) (0.01 mole) and 2-((2-methylquinolin-8-yl)oxy)acetohydrazide(3) (0.01 mole) in ethanol (20 mL) was heated under reflux for 8 h on a water bath. After completion of the reaction, ethanol was evaporated; the residue was dissolved in water, neutralized with NaHCO 3 and extracted with ether. The ether solution was evaporated under reduced pressure to furnish the pure compound. 122.4, 134.7, 121.5, 124.3, 112.3, 154.7, 140.4, 129.3 (quinoline ring) Methyl-1-(2-((2-methylquinolin-8-yl) 
3-Methyl-1-(2-((2-methylquinolin-8-yl)oxy)acetyl)-4-(2-phenylhydrazono)-1H-pyrazol-5(4H)-one (9a)
4-(2-(4-Methoxyphenyl)hydrazono)-3-methyl-1-(2-((2-methylquinolin-8-yl) oxy)acetyl)-1H-pyrazol-5(4H)-one (9b)
4-(2-(3-Methyl-1-(2-((2-methylquinolin-8-yl)oxy)acetyl)-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)benzenesulfonamide (9c)
4-(2-(4-Chlorophenyl)hydrazono)-3-methyl-1-(2-((2-methylquinolin-8-yl)oxy)acetyl)-1H-pyrazol-5(4H)-one (9d)
3-Methyl-1-(2-((2-methylquinolin-8-yl)oxy)acetyl)-4-(2-(4-nitrophenyl) hydrazono)-1H-pyrazol-5(4H)-one (9e)
4-(2-(2-Methoxyphenyl)hydrazono)-3-methyl-1-(2-((2-methylquinolin-8-yl)oxy) acetyl)-1H-pyrazol-5(4H)-one (9f)
4-(2-(2-Chlorophenyl)hydrazono)-3-methyl-1-(2-((2-methylquinolin-8-yl)oxy) acetyl)-1H-pyrazol-5(4H)-one (9g)
3-
Results and Discussion
The synthesised compounds 8a-g and 9a-h were prepared as depicted in Scheme 1. Initially, ethyl 2-((2-methylquinolin-8-yl)oxy)acetate (2) was prepared by agitating a mixture of 2-methylquinolin-8-ol (1) with ethyl chloroacetate in the presence of K 2 CO 3 in DMF. Compound (2) was converted into corresponding acetohydrazide by heating with hydrazine hydrate to give 2-((2-methylquinolin-8-yl)oxy)acetohydrazide (3). The reaction of aryl diazonium chloride (5a-h) with acetylacetone and ethyl acetoacetate yielded the corresponding 3-(phenyldiazenyl)pentane-2,4-dione (6a-g) and ethyl 3-oxo-2-(2-phenylhydrazono)butanoate (7a-h). Reaction of compound (3) with 6a-g in ethanol resulted in the formation of 1-(3,5-dimethyl-4-(substitutedphenyldiazenyl)-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl)oxy)ethanones (8a-g) in good yields. IR spectrum of 8a revealed a band at 1415 cm -1 due to N=N group. The 1 H NMR spectrum of 8a showed two singlets at δ 2.26, 2.47 indicating the presence of a pair of CH 3 groups in the pyrazole ring. A singlet was also observed at δ 4.82 due to OCH 2 protons. The mass spectrum of 8a showed a peak at m/z 400.17 corresponding to [M+H] ion.
Reaction of compound (3) with 7a-h in ethanol resulted in the formation of 3-methyl-1-(2-((2-methylquinolin-8-yl)oxy)acetyl)-4-(2-substitutedphenylhydrazono)-1H-pyrazol-5(4H)-one (9a-h) in good yields. The spectral data of 9a-g confirmed that these compounds exist in hydrazono form. The spectral data of 9a revealed a strong absorption band at 1640 cm -1 due to C=O group. Low frequency carbonyl band may be assigned to C=O group in pyrazolin-5-one participating in intra-molecular hydrogen-bonding with NH group. The 1 H NMR spectrum of 9a, showed a singlet at δ 11.63 due to the presence of hydrogen-bonded NH group. The mass spectrum of 9a showed a peak at m/z 402.15 corresponding to [M+H] ion.
Elemental analyses and spectral data of 8a-g and 9a-h are consistent with the assigned structures (c.f. Experimental section). The results of antimicrobial studies are summarized in 23, 24 .
The investigation of antibacterial screening data revealed that all the tested compounds showed moderate to good bacterial inhibition. But majority of the compounds did not exhibit any significant antifungal inhibition.
All the tested compounds were found to be potent against Gram-positive bacteria Staphylococcus aureus and Bacillus subtilis. Among them compounds 8a, 8b, 8d, 9d and 9f were found to be more potent against Staphylococcus aureus. Compounds 3, 8a, 8b, 9a, 9b and 9d were found to more potent against Bacillus subtilis. Similarly all tested compounds were found to be potent against Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi. Compounds 3, 8d and 9b were found to be more potent against Escherichia coli. Compounds 8d and 9d were found to be more potent against Pseudomonas aeruginosa. Compounds 8a, 8b, 8d, 8e, 9d and 9f were found to be more potent against Salmonella typhi.
But majority of the compounds did not exhibit any significant antifungal activity against A. Niger and U. maydis. Only compounds 3, 9c and 9d showed feeble activity against A. Niger where as compounds 3, 8a, 9a and 9d exhibited feeble activity against U. maydis.
Conclusion
The compounds 1-(3,5-dimethyl-4-(substitutedphenyldiazenyl)-1H-pyrazol-1-yl)-2-((2-methylquinolin-8-yl)oxy)ethanones (8a-g) and 3-methyl-1-(2-((2-methylquinolin-8-yl)oxy)acetyl)-4-(2-substitutedphenylhydrazono)-1H-pyrazol-5(4H)-ones (9a-h) were synthesized by combining 2-methylquinoline ring with pyrazole and pyrazolin-5-one scaffolds respectively. The spectral data are consistent with the structure of the newly synthesized compounds. The antimicrobial activity of the synthesized compounds was evaluated by disc diffusion method. The results revealed that all the compounds synthesized exhibited moderate to good antibacterial activity.
